ESG

A new partnership automates data flow for 2,500+ research sites, promising near-perfect accuracy and faster drug development. Here’s how it works.

A national network is expanding its specialized centers, offering a new model of lifetime care to combat years of diagnostic delays and dismissed pain.

Hinch Distillery's major award win is an early victory for new Head Distiller Emma Millar, signaling a new era of craft and innovation in Irish whiskey.

A new partnership aims to use light and AI to break bottlenecks in drug development, promising to make personalized medicine faster and more accessible.

Fresh off a blockbuster IPO, SpyGlass Pharma heads to a key investor summit. Can its revolutionary long-acting drug platform transform chronic eye care?

As new U.S. regulations loom, Mary Kay's ISO 22716 certification signals a new era of quality, safety, and consumer trust in the cosmetics industry.

Celebrating 100,000 home sales, Godrej Properties gifted a family a free home, a move that redefines brand loyalty in India's real estate market.

An injured 'begging' elephant's rescue via a state-of-the-art ambulance highlights a new chapter in the fight against animal exploitation in India.

The water solutions giant unveiled ambitious new financial targets, aiming to capitalize on water scarcity and infrastructure needs while reassuring investors.

A landmark draft permit advances a first-of-its-kind project in Louisiana, promising carbon-negative power, SAF, and a major economic boost for the region.

As US energy demand soars, construction titan Clayco launches a new unit to build utility-scale solar and battery projects, betting on its integrated model.

A nonprofit's initiative just gave its 4 millionth free vaccine, revealing a strategic model that tackles pet health crises and opens doors to lifelong care.

On World Engineering Day, Zendure unveiled an AI-powered ecosystem and new solar storage, aiming to slash energy bills and challenge rivals in Europe.

A new partnership integrates advanced AI for brain lesion tracking into a global imaging network, promising safer Alzheimer's treatments and faster diagnostics.

Theolytics secures a prestigious €8 million EU grant to advance its unique cancer-killing virus, offering new hope for hard-to-treat ovarian cancer.

As a deadly superbug spreads, BioVersys's BV100 enters late-stage trials, backed by promising data and a novel scientific approach to combat resistance.

The WPIC forecasts another major platinum deficit for 2026, signaling continued market tightness, price support, and a complex global supply struggle.

Jordan Faeth of Netflix's 'Love is Blind' is using his fame to tackle a silent epidemic affecting millions, destigmatizing sleep apnea one breath at a time.

Immunome announces stellar Phase 3 data for its desmoid tumor drug, varegacestat, and details a robust, well-funded ADC pipeline aimed at solid tumors.

As data centers face an energy crisis, a new exec hire at TRIMAX signals a strategic push into the lucrative secondary power market.